Long-term outcomes in patients with porto-sinusoidal vascular disorder: a single-centre 10-year follow-up study
- 7 January 2026
- journal article
- Published by BMJ in Frontline Gastroenterology
Abstract
Objective: Porto-sinusoidal vascular disorder (PSVD) is a recently described nomenclature with limited data on long-term outcomes. We evaluated the outcomes in a cohort of PSVD patients and determined whether these differed from patients classified as per the previous idiopathic non-cirrhotic portal hypertension (INCPH) criteria. Design: In this single-centre retrospective study, baseline characteristics and liver-related outcomes were evaluated in patients with PSVD. The prognostic performance of the nomogram from the Vascular Liver Disease Group (VALDIG) consortium was assessed. Outcomes were compared in patients categorised as PSVD (PSVD+/INCPH-) as per new nomenclature with those who, in addition, fulfilled previous INCPH (PSVD+/INCPH+) criteria. Results: Eighty patients were included (mean age: 44 years and 38% females). History of PH-related complications was present in 36 (45%) patients at diagnosis. Median follow-up duration from diagnosis was 78 (IQR: 27–132) months. The cumulative 5-year and 10-year probability of liver-related events was as follows: PH-related bleed (15.4% and 21.8%), new onset/worsening ascites (21.6% and 35%), splanchnic vein thrombosis (15.9% and 21%) and transplant-free survival (70.5% and 60.72%), respectively. The VALDIG nomogram showed good discrimination (optimism-corrected C-statistic: 0.769) but over-estimated survival. Patients classified as PSVD+/INCPH+ (n=26) were younger (mean age: 39 vs 48 years, p=0.013), had a higher prevalence of varices (92% vs 59%, p=0.027), but had similar outcomes (10-year survival: 63.5% vs 59.3%; HR, 0.76 (95% CI 0.33 to 1.75), p=0.52) compared with the PSVD+/INCPH− group (n=54). Conclusion: This study describes long-term outcomes in PSVD from a quaternary centre. VALDIG prognostic nomogram may need recalibration through further external validation. Outcomes were similar irrespective of the nomenclature used to define this cohort.Keywords
This publication has 21 references indexed in Scilit:
- Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and managementHepatology International, 2024
- Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertensionJournal of Gastroenterology, 2023
- Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionClinical Gastroenterology and Hepatology, 2022
- Idiopathic Portal HypertensionHepatology, 2018
- Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosisDigestive and Liver Disease, 2018
- Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertensionHepatology, 2016
- Idiopathic portal hypertension: Natural history and long-term outcomeHepatology, 2013
- Obliterative portal venopathy: Portal hypertension is not always present at diagnosisJournal of Hepatology, 2011
- Non-cirrhotic Intrahepatic Portal Hypertension: Associated Gut Diseases and Prognostic FactorsDigestive Diseases and Sciences, 2010
- Liver Transplantation for Severe Intrahepatic Noncirrhotic Portal HypertensionLiver Transplantation, 2005